Resultados de la búsqueda 801-810 of 7320 for pilule du lendemain

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the effects of ibrutinib and rituximab with or without venetoclax in treating patients with previously untreated ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  3. Neurología - Ensayos clínicos

    The purpose of this study is so that blood (plasma and blood cells) and/or extra spinal fluid (which was taken for clinical purposes) can be obtained and ...

  4. Mayo Clinic

    Share · Tweet . IMG-20520979. Inicio; cc-woman-aspirin-bottle_thumbnail. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  5. Ensayos clínicos - Medicina cardiovascular

    Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) or cardiac ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...

  9. Oncología (médica) - Ensayos clínicos

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...

  10. Oncología (médica) - Ensayos clínicos

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...